Eva Feldman
#27,263
Most Influential Person Now
American neurologist
Eva Feldman's AcademicInfluence.com Rankings
Eva Feldmanmedical Degrees
Medical
#535
World Rank
#726
Historical Rank
Rehabilitation Medicine
#1
World Rank
#1
Historical Rank
Neurology
#54
World Rank
#95
Historical Rank
Download Badge
Medical
Why Is Eva Feldman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Eva Lucille Feldman is an American physician-scientist who is a leading authority on neurodegenerative disease. She serves as the Russell N. DeJong Professor of Neurology at the University of Michigan, as well as Director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine. She was also named the James W. Albers Distinguished University Professor of Neurology.
Eva Feldman's Published Works
Published Works
- Diabetic neuropathies: a statement by the American Diabetes Association. (2005) (1886)
- Diabetic Neuropathy: A Position Statement by the American Diabetes Association (2016) (1286)
- A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy (1994) (1067)
- Oxidative stress in the pathogenesis of diabetic neuropathy. (2004) (876)
- Diabetic neuropathy: clinical manifestations and current treatments (2012) (805)
- Diabetic neuropathy: mechanisms to management. (2008) (681)
- Amyotrophic lateral sclerosis (2022) (515)
- New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain (2017) (491)
- High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons (2002) (472)
- The insulin-like growth factor system and its pleiotropic functions in brain. (2005) (456)
- Diabetic neuropathy: cellular mechanisms as therapeutic targets (2011) (436)
- Genome-wide Analyses Identify KIF5A as a Novel ALS Gene (2018) (414)
- Neurons Undergo Apoptosis in Animal and Cell Culture Models of Diabetes (1999) (404)
- Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome (1990) (397)
- Microvascular complications of impaired glucose tolerance. (2003) (385)
- Aligned electrospun nanofibers specify the direction of dorsal root ganglia neurite growth. (2007) (370)
- How does diabetes accelerate Alzheimer disease pathology? (2010) (360)
- Evidence-based guideline: Treatment of painful diabetic neuropathy (2011) (352)
- Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. (2006) (348)
- Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study (2010) (330)
- Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (2012) (324)
- Complications: Neuropathy, Pathogenetic Considerations (1992) (305)
- Control of cell survival by IGF signaling pathways. (2002) (304)
- Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy (2009) (286)
- Short‐term hyperglycemia produces oxidative damage and apoptosis in neurons (2005) (280)
- Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) (2009) (273)
- Pathogenesis of diabetic neuropathy. (1989) (266)
- Neurological consequences of obesity (2017) (262)
- Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies (1990) (261)
- Chronic inflammatory demyelinating polyradiculoneuropathy (1992) (259)
- Lumbar Intraspinal Injection of Neural Stem Cells in Patients with Amyotrophic Lateral Sclerosis: Results of a Phase I Trial in 12 Patients (2012) (257)
- Oxidative stress and diabetic neuropathy: a new understanding of an old problem. (2003) (254)
- Insulin resistance in the nervous system (2012) (252)
- Mechanisms of disease: The oxidative stress theory of diabetic neuropathy (2008) (245)
- Stem cell technology for neurodegenerative diseases (2011) (235)
- Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome (2015) (233)
- Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. (1999) (231)
- Evidence‐based Guideline: Treatment of Painful Diabetic Neuropathy (2011) (222)
- Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. (2009) (219)
- The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. (1994) (218)
- Loss of Myotubularin Function Results in T-Tubule Disorganization in Zebrafish and Human Myotubular Myopathy (2009) (213)
- From Fibrosis to Sclerosis (2008) (212)
- Mouse models of diabetic neuropathy (2007) (210)
- Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. (2007) (208)
- Immunosuppressive treatment in multifocal motor neuropathy (1991) (199)
- Insulin-like Growth Factors Regulate Neuronal Differentiation and Survival (1997) (196)
- Infection of the retina by human immunodeficiency virus type I. (1987) (193)
- Signaling mechanisms that regulate actin‐based motility processes in the nervous system (2002) (190)
- Enhanced glucose control for preventing and treating diabetic neuropathy. (2012) (189)
- Insulin-like growth factor-I and central nervous system development. (1999) (189)
- Intraspinal Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: Phase 1 Trial Outcomes (2014) (187)
- Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease (2014) (184)
- Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study (2017) (181)
- New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism (2019) (178)
- Diabetic neuropathy. (2019) (177)
- Type I Insulin-like Growth Factor Receptor Activation Regulates Apoptotic Proteins* (1996) (176)
- SUMOylation of the mitochondrial fission protein Drpl occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle (2009) (175)
- Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era (2015) (173)
- A Multicenter Study on the Prevalence of Diabetic Neuropathy in Italy (1997) (172)
- Insulin‐like growth factor I rescues SH‐SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death (1996) (170)
- Insulin-like Growth Factor-I-mediated Neurite Outgrowth in Vitro Requires Mitogen-activated Protein Kinase Activation* (1997) (168)
- Distal Symmetric Polyneuropathy: A Review. (2015) (165)
- Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. (2016) (162)
- Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin‐associated glycoprotein (1991) (161)
- Hyperlipidemia: a new therapeutic target for diabetic neuropathy (2009) (159)
- Neuroinflammation, COX-2, and ALS—a dual role? (2004) (157)
- The Persian Gulf Experience and Health (1994) (157)
- Dyslipidemia-Induced Neuropathy in Mice : the Role of oxLDL / LOX-1 (2009) (155)
- The design of electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons. (2008) (154)
- Diabetic neuropathy (2019) (154)
- Tyrosine Phosphorylation of Paxillin and Focal Adhesion Kinase during Insulin-like Growth Factor-I-stimulated Lamellipodial Advance* (1997) (150)
- The role of growth factors in diabetic peripheral neuropathy (2004) (150)
- Phosphatidylinositol 3‐kinase and Akt effectors mediate insulin‐like growth factor‐I neuroprotection in dorsal root ganglia neurons (2004) (150)
- IGF-I prevents glutamate-induced motor neuron programmed cell death (2004) (149)
- Epigenetic Changes in Bone Marrow Progenitor Cells Influence the Inflammatory Phenotype and Alter Wound Healing in Type 2 Diabetes (2014) (148)
- Perspective: Transforming Science Into Medicine How Clinician–Scientists Can Build Bridges Across Research's “Valley of Death” (2012) (144)
- The Aetiology of Diabetic Neuropathy: the Combined Roles of Metabolic and Vascular Defects (1995) (144)
- Diabetes regulates mitochondrial biogenesis and fission in mouse neurons (2009) (142)
- Kindlin-2 Is an Essential Component of Intercalated Discs and Is Required for Vertebrate Cardiac Structure and Function (2008) (141)
- Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy (1993) (140)
- Inflammation as a Therapeutic Target for Diabetic Neuropathies (2016) (140)
- Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. (1996) (136)
- Diabetic neuropathy: one disease or two? (2012) (135)
- Update on diabetic neuropathy (2002) (135)
- Subcutaneous IGF-1 is not beneficial in 2-year ALS trial (2008) (134)
- New insights into the pathogenesis of diabetic neuropathy. (1999) (132)
- Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis (2012) (130)
- Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy (2010) (130)
- The identification of gene expression profiles associated with progression of human diabetic neuropathy. (2011) (130)
- Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. (1998) (129)
- Dyslipidemia-Induced Neuropathy in Mice (2009) (127)
- Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. (1995) (126)
- Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. (2012) (126)
- Diabetic neuropathy: scope of the syndrome. (1999) (126)
- DCCT and EDIC Studies in Type 1 Diabetes: Lessons for Diabetic Neuropathy Regarding Metabolic Memory and Natural History (2010) (125)
- Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab) (2014) (124)
- Mechanisms of Disease: mitochondria as new therapeutic targets in diabetic neuropathy (2006) (124)
- Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. (1998) (122)
- Insulin‐Like Growth Factor‐I and Over‐Expression of Bcl‐xL Prevent Glucose‐Mediated Apoptosis in Schwann Cells (2001) (121)
- Transplantation of spinal cord–derived neural stem cells for ALS (2016) (118)
- An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. (2013) (118)
- Bidirectional Regulation of p38 Kinase and c-Jun N-terminal Protein Kinase by Insulin-like Growth Factor-I* (1998) (117)
- Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population. (2016) (117)
- Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1 (2006) (115)
- Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice (2010) (115)
- Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status (2016) (112)
- Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis (2012) (110)
- Characterization of Insulin‐Like Growth Factor‐I and Its Receptor and Binding Proteins in Transected Nerves and Cultured Schwann Cells (1996) (109)
- Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark (2018) (108)
- Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression (2017) (107)
- The metabolic syndrome and neuropathy: Therapeutic challenges and opportunities (2013) (106)
- SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy (2007) (105)
- Mouse models of diabetic neuropathy. (2014) (104)
- Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose. (1999) (104)
- Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials (2001) (104)
- Diabetes and obesity are the main metabolic drivers of peripheral neuropathy (2018) (103)
- Human Neural Stem Cell Replacement Therapy for Amyotrophic Lateral Sclerosis by Spinal Transplantation (2012) (102)
- Association of Environmental Toxins With Amyotrophic Lateral Sclerosis. (2016) (102)
- Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells. (1999) (100)
- From Fibrosis to Sclerosis Mechanisms of Glomerulosclerosis in Diabetic (2008) (99)
- Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis (2019) (98)
- Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes. (2014) (97)
- Zebrafish models of collagen VI-related myopathies (2010) (97)
- SciMiner: web-based literature mining tool for target identification and functional enrichment analysis (2009) (95)
- Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. (2009) (95)
- 25 years of neuroimaging in amyotrophic lateral sclerosis (2013) (94)
- Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. (2011) (93)
- Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes. (2013) (90)
- The Association of Exposure to Lead, Mercury, and Selenium and the Development of Amyotrophic Lateral Sclerosis and the Epigenetic Implications (2010) (89)
- Abnormal RNA stability in amyotrophic lateral sclerosis (2018) (89)
- Oxidative injury and neuropathy in diabetes and impaired glucose tolerance (2008) (88)
- Insulin-like growth factor-I signaling in human neuroblastoma cells (2004) (87)
- Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity (2019) (87)
- Clinical Testing in Diabetic Peripheral Neuropathy (1994) (86)
- Kindlin-2 is required for myocyte elongation and is essential for myogenesis (2008) (85)
- Transcriptional Profiling of Diabetic Neuropathy in the BKS db/db Mouse (2011) (85)
- Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy. (2014) (85)
- GTPases and phosphatidylinositol 3-kinase are critical for insulin-like growth factor-I-mediated Schwann cell motility. (2000) (85)
- Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan (2014) (85)
- Nerve Growth Factor Mediates Mechanical Allodynia in a Mouse Model of Type 2 Diabetes (2009) (84)
- New Insights into the Mechanisms of Diabetic Neuropathy (2004) (82)
- Peripheral Neuropathy in Adolescents and Young Adults With Type 1 and Type 2 Diabetes From the SEARCH for Diabetes in Youth Follow-up Cohort (2013) (82)
- Insulin Receptor Substrate 2 And Shc Play Different Roles In Insulin-like Growth Factor I Signaling* (1998) (80)
- Zebrafish MTMR14 is required for excitation-contraction coupling, developmental motor function and the regulation of autophagy. (2010) (80)
- Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy. (2013) (78)
- Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes. (2011) (78)
- Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes (2010) (78)
- Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone. (2006) (76)
- Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. (2013) (76)
- Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS (2009) (75)
- Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. (2008) (75)
- Accelerated neuritogenesis and maturation of primary spinal motor neurons in response to nanofibers (2010) (75)
- Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation. (2009) (75)
- Insulin-like Growth Factor-I in Muscle Metabolism and Myotherapies (2001) (74)
- Skeletal muscle weakness due to deficiency of CuZn-superoxide dismutase is associated with loss of functional innervation. (2011) (74)
- Vascular endothelial growth factor prevents G93A‐SOD1‐induced motor neuron degeneration (2009) (74)
- Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study (2020) (73)
- PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models. (2016) (73)
- mnd2: a new mouse model of inherited motor neuron disease. (1993) (73)
- Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy. (2012) (73)
- Translational stem cell therapy for amyotrophic lateral sclerosis (2012) (72)
- COVID-19 and Diabetes: A Collision and Collusion of Two Diseases (2020) (72)
- Abnormal Muscle Spindle Innervation and Large-Fiber Neuropathy in Diabetic Mice (2008) (72)
- Stem cell technology for the study and treatment of motor neuron diseases. (2011) (70)
- Studies on the localization of newly added membrane in growing neurites. (1981) (70)
- Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat. (1996) (70)
- Caveolin‐1 expression in Schwann cells (1999) (68)
- IGF-I promotes Schwann cell motility and survival via activation of Akt (2000) (68)
- Mediators of diabetic neuropathy: is hyperglycemia the only culprit? (2017) (68)
- Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy (2013) (68)
- Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage. (1993) (67)
- Insulin-like Growth Factors as Regulators of Cell Motility Signaling Mechanisms (1997) (67)
- Insulin‐like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic‐induced apoptosis (2000) (67)
- Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery (2003) (67)
- Concise Review: Stem Cell Therapies for Amyotrophic Lateral Sclerosis: Recent Advances and Prospects for the Future (2014) (67)
- Insulin-like growth factor I stimulates motility in human neuroblastoma cells (2001) (67)
- New developments in diabetic neuropathy (2005) (66)
- Criteria for creating and assessing mouse models of diabetic neuropathy. (2008) (66)
- The antioxidant response as a drug target in diabetic neuropathy. (2008) (66)
- Human neural stem cell transplantation improves cognition in a murine model of Alzheimer’s disease (2018) (65)
- Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. (2005) (65)
- Gene expression of the insulin-like growth factors and their receptors in cultured human retinal pigment epithelial cells. (1992) (65)
- Substrate patterning: an emerging technology for the study of neuronal behavior (2003) (64)
- Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms (2016) (64)
- High‐titer selective serum anti‐β‐tubulin antibodies in chronic inflammatory demyelinating polyneuropathy (1993) (63)
- Neuromuscular effects of G93A-SOD1 expression in zebrafish (2012) (63)
- Polyneuropathy with impaired glucose tolerance: Implications for diagnosis and therapy (2005) (63)
- ER stress in diabetic peripheral neuropathy: A new therapeutic target. (2014) (63)
- The dual roles of immunity in ALS: Injury overrides protection (2015) (61)
- Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis (2005) (61)
- p38 mediates mechanical allodynia in a mouse model of type 2 diabetes (2010) (61)
- Differential Regulation of Focal Adhesion Kinase and Mitogen‐Activated Protein Kinase Tyrosine Phosphorylation During Insulin‐Like Growth Factor‐I‐Mediated Cytoskeletal Reorganization (1998) (60)
- Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells. (1995) (60)
- The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review. (2015) (60)
- Immunohistochemical localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 during development in the rat brain. (1994) (60)
- Peripheral nervous system insulin resistance in ob/ob mice (2013) (59)
- IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma (2000) (59)
- Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells (1997) (59)
- Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis (1993) (59)
- Cervical Multilevel Intraspinal Stem Cell Therapy: Assessment of Surgical Risks in Gottingen Minipigs (2011) (59)
- The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice (2010) (58)
- IGFs and the Nervous System (1999) (58)
- Biology of diabetic neuropathy. (2013) (58)
- Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization (2018) (58)
- Diabetic neuropathy: what does the future hold? (2020) (58)
- Integrin expression regulates neuroblastoma attachment and migration. (2004) (58)
- Intraneural Colchicine Inhibition of Adenoviral and Adeno-associated Viral Vector Remote Spinal Cord Gene Delivery (2003) (58)
- Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis (2009) (57)
- Disorders of cranial nerves IX and X. (2009) (57)
- Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer’s Disease (2016) (56)
- Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease. (2013) (56)
- Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study (2018) (55)
- BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses (2015) (55)
- Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice. (2008) (55)
- N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells (2002) (54)
- Tyrosine Phosphorylation and Enhanced Expression of Paxillin during Neuronal Differentiation in Vitro(*) (1996) (54)
- Bioenergetics in diabetic neuropathy: what we need to know (2012) (53)
- Dietary reversal of neuropathy in a murine model of prediabetes and metabolic syndrome (2017) (53)
- Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians. (2019) (52)
- Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis (2016) (51)
- Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons (2018) (51)
- Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery (2009) (50)
- Mitochondrial DNA (mtDNA) Biogenesis: Visualization and Duel Incorporation of BrdU and EdU Into Newly Synthesized mtDNA In Vitro (2010) (50)
- Schwann cell caveolin‐1 expression increases during myelination and decreases after axotomy (2002) (49)
- Characterization of adenoviral gene expression in spinal cord after remote vector delivery. (1999) (48)
- Central nervous system endoplasmic reticulum stress in a murine model of type 2 diabetes (2012) (47)
- Membrane Traffic and Muscle: Lessons from Human Disease (2008) (47)
- The myopathy-causing mutation DNM2-S619L leads to defective tubulation in vitro and in developing zebrafish (2013) (47)
- Insulin-like growth factor I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells. (1993) (47)
- Analysis of graft survival in a trial of stem cell transplant in ALS (2014) (46)
- Dysphagia in elderly men with myasthenia gravis (1996) (46)
- Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes (2012) (46)
- The Role of Oxidative Stress in Nervous System Aging (2013) (45)
- Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial (2013) (45)
- Insulin-like growth factor-I regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma (2004) (45)
- Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice (2019) (45)
- Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation* (2015) (44)
- Regulation of insulin‐like growth factor‐II expression and its role in autocrine growth of human neuroblastoma cells (1993) (44)
- Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis (2022) (44)
- Tests and expenditures in the initial evaluation of peripheral neuropathy. (2012) (43)
- Triglycerides and Amputation Risk in Patients With Diabetes (2011) (43)
- Insulin‐like growth factor‐I (IGF‐I) and IGF binding protein‐5 in Schwann cell differentiation (1997) (43)
- Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis (2014) (43)
- Insulin-like growth factor II in the pathogenesis of human neuroblastoma. (1995) (43)
- Insulin-like growth factors in the treatment of neurological disease. (2005) (42)
- The management of diabetic neuropathy in CKD. (2010) (42)
- Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy (2003) (42)
- The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes (2015) (42)
- Insulin-like Growth Factor I Prevents Mannitol-induced Degradation of Focal Adhesion Kinase and Akt* (2002) (41)
- Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells (2005) (41)
- Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. (1998) (41)
- Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction. (2014) (40)
- Surgical Decompression for Diabetic Sensorimotor Polyneuropathy (2007) (40)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- Long‐term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS (2018) (40)
- Intraspinal stem cell transplantation for amyotrophic lateral sclerosis (2016) (39)
- Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials (2019) (39)
- Gene expression of the insulin-like growth factors and their receptors in human neuroblastoma cell lines. (1992) (39)
- Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network (2011) (39)
- N-Myc overexpression leads to decreased β1 integrin expression and increased apoptosis in human neuroblastoma cells (2003) (38)
- Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. (2021) (38)
- Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression (2009) (38)
- Notch Signaling Regulates Motor Neuron Differentiation of Human Embryonic Stem Cells (2015) (38)
- Effects of serum and insulin-like growth factors on human neuroblastoma cell growth (1993) (37)
- The Divergent Roles of Dietary Saturated and Monounsaturated Fatty Acids on Nerve Function in Murine Models of Obesity (2019) (37)
- Insulin-like growth factors in the peripheral nervous system. (2012) (37)
- Receptor‐Coupled Phosphoinositide Hydrolysis in Human Retinal Pigment Epithelium (1991) (36)
- IGF-I promotes peripheral nervous system myelination. (1999) (36)
- Untargeted metabolomics yields insight into ALS disease mechanisms (2020) (35)
- Cofilin activity during insulin-like growth factor I-stimulated neuroblastoma cell motility (2005) (35)
- Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis (2022) (35)
- Comparative RNA‐Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease (2017) (35)
- Literature-based discovery of diabetes- and ROS-related targets (2010) (34)
- Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study. (2015) (34)
- Longitudinal assessment of noninvasive positive pressure ventilation adjustments in ALS patients (2006) (34)
- Insulin-like growth factors in the peripheral nervous system. (2008) (34)
- Longitudinal patient-oriented outcomes in neuropathy (2015) (34)
- Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes (2019) (34)
- Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy (2013) (34)
- Conserved Transcriptional Signatures in Human and Murine Diabetic Peripheral Neuropathy (2018) (33)
- Immunohistochemical localization of insulin-like growth factor binding protein-5 in the developing rat nervous system. (1996) (33)
- Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story (2018) (33)
- Interferon‐γ inhibits DNA synthesis and insulin‐like growth factor‐II expression in human neuroblastoma cells (1993) (33)
- Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance (1993) (33)
- IGF receptor function and regulation in autocrine human neuroblastoma cell growth (1993) (32)
- Insulin‐like growth factor‐I and Bcl‐XL inhibit c‐jun N‐terminal kinase activation and rescue Schwann cells from apoptosis (2001) (32)
- Neuronal survival following remote adenovirus gene delivery. (2002) (32)
- Central Obesity is Associated With Neuropathy in the Severely Obese. (2020) (31)
- Histological localization of binding sites of α-bungarotoxin and of antibodies specific to acetylcholine receptor in goldfish optic nerve and tectum (1980) (31)
- Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells. (2003) (31)
- PTEN/MMAC1 overexpression decreases insulin-like growth factor-I-mediated protection from apoptosis in neuroblastoma cells. (2001) (31)
- Dietary Reversal Ameliorates Short- and Long-Term Memory Deficits Induced by High-fat Diet Early in Life (2016) (31)
- Shared and distinct lipid-lipid interactions in plasma and affected tissues in a diabetic mouse model[S] (2017) (31)
- Differences between collagen morphologies, properties and distribution in diabetic and normal biobreeding and Sprague-Dawley rat sciatic nerves. (2004) (30)
- Strategic approaches to developing drug treatments for ALS. (2008) (30)
- The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease (2019) (30)
- Gender-specific differences in diabetic neuropathy in BTBR ob/ob mice. (2016) (30)
- Regulation of insulin-like growth factor-binding protein-5 expression during Schwann cell differentiation. (1999) (30)
- Optimization of Immunosuppressive Therapy for Spinal Grafting of Human Spinal Stem Cells in a Rat Model of ALS (2011) (30)
- Identification of Factors Associated With Sural Nerve Regeneration and Degeneration in Diabetic Neuropathy (2013) (30)
- Delivery of an Adenoviral Vector to the Crushed Recurrent Laryngeal Nerve (2003) (30)
- Mannose 6-phosphate potentiates insulin-like growth factor II effects in cultured human neuroblastoma cells (1991) (29)
- Patterning N-type and S-type neuroblastoma cells with Pluronic F108 and ECM proteins. (2009) (29)
- Toll-like receptors and inflammation in metabolic neuropathy; a role in early versus late disease? (2019) (28)
- Chain length of saturated fatty acids regulates mitochondrial trafficking and function in sensory neurons (2018) (28)
- Diabetic cardiac autonomic neuropathy: Insights from animal models (2013) (28)
- Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy (2020) (28)
- Triglycerides and Amputation Risk in PatientsWith Diabetes Ten-year follow-up in the DISTANCE study (2011) (28)
- Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns (2016) (28)
- Juvenile murine models of prediabetes and type 2 diabetes develop neuropathy (2018) (28)
- Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis (2021) (27)
- Autocrine Production of IGF‐I Increases Stem Cell‐Mediated Neuroprotection (2015) (27)
- IGF and Nutrition in Health and Disease (2004) (27)
- The emerging role of dyslipidemia in diabetic microvascular complications. (2020) (27)
- Neurodegeneration and early lethality in superoxide dismutase 2-deficient mice: A comprehensive analysis of the central and peripheral nervous systems (2012) (27)
- Metabolic Factors, Lifestyle Habits, and Possible Polyneuropathy in Early Type 2 Diabetes: A Nationwide Study of 5,249 Patients in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Cohort (2020) (26)
- Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro (2007) (26)
- High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis (2019) (26)
- Reduced intraepidermal nerve fiber density after a sustained increase in insular glutamate: a proof-of-concept study examining the pathogenesis of small fiber pathology in fibromyalgia (2017) (26)
- The role of endoplasmic reticulum stress in hippocampal insulin resistance (2016) (25)
- Global Metabolomic and Isobaric Tagging Capillary Liquid Chromatography–Tandem Mass Spectrometry Approaches for Uncovering Pathway Dysfunction in Diabetic Mouse Aorta (2014) (25)
- The Prevalence and Determinants of Cognitive Deficits and Traditional Diabetic Complications in the Severely Obese (2020) (25)
- Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes (2016) (25)
- Acute pandysautonomic neuropathy (1991) (24)
- The role of MTMR14 in autophagy and in muscle disease (2010) (24)
- Regulation of insulin‐like growth factor binding protein synthesis and secretion in human retinal pigment epithelial cells (1994) (24)
- Remote Delivery of rAAV‐GFP to the Rat Brainstem Through the Recurrent Laryngeal Nerve (2001) (24)
- Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis (2009) (24)
- DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes (2020) (24)
- Granulomatous myositis, primary biliary cirrhosis, pancytopenia, and thymoma (2000) (24)
- The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice. (2012) (23)
- Disorders of mitochondrial dynamics in peripheral neuropathy: Clues from hereditary neuropathy and diabetes. (2019) (23)
- Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture. (1993) (23)
- Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis (2015) (23)
- Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists (2018) (23)
- Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19 (2022) (23)
- Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis. (2018) (23)
- Status epilepticus amauroticus (1997) (22)
- Amyotrophic lateral sclerosis (2022) (22)
- The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain (2015) (22)
- THE PREVALENCE, IMPACT, AND MULTIFACTORIAL PATHOGENESIS OF DIABETIC PERIPHERAL NEUROPATHY (2004) (22)
- Integrated Systems Pharmacology Analysis of Clinical Drug-Induced Peripheral Neuropathy (2014) (22)
- Altered plasma serine and 1-deoxydihydroceramide profiles are associated with diabetic neuropathy in type 2 diabetes and obesity. (2021) (21)
- Microvascular Complications of Impaired Glucose (2003) (21)
- Bcl-2 and N-Myc Coexpression Increases IGF-IR and Features of Malignant Growth in Neuroblastoma Cell Lines (2001) (21)
- The retina as a biochemical model of central nervous system regeneration (1980) (21)
- Early life metal dysregulation in amyotrophic lateral sclerosis (2020) (20)
- Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts? (2013) (20)
- Dysfunction of the Recurrent Laryngeal Nerve and the Potential of Gene Therapy (2007) (20)
- Diabetic Peripheral and Autonomic Neuropathy (2003) (20)
- Spontaneous laryngeal reinnervation following chronic recurrent laryngeal nerve injury (2013) (20)
- Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? (2016) (20)
- Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus (2019) (19)
- The pleotrophic effects of insulin-like growth factor-I on human spinal cord neural progenitor cells. (2010) (18)
- Cardiovascular autonomic neuropathy associates with nephropathy lesions in American Indians with type 2 diabetes. (2016) (18)
- IGF‐I Promotes Peripheral Nervous System Myelination (1999) (18)
- Two Dynamin-2 Genes Are Required for Normal Zebrafish Development (2013) (17)
- National Institute of Neurological Disorders and Stroke (NINDS): Advances in understanding and treating neuropathy, 24–25 October 2006; Bethesda, Maryland (2008) (17)
- Regulation of Insulin-Like Growth Factor-Binding Protein-5 Expression during Schwann Cell Differentiation1. (1999) (17)
- Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells (1997) (17)
- Hyperglycemia- and neuropathy-induced changes in mitochondria within sensory nerves (2014) (17)
- Importance and hurdles to drug discovery for neurological disease (2013) (17)
- Therapy for diabetic neuropathy: an overview. (2014) (17)
- Identification of candidate drugs for the treatment of ALS (2005) (17)
- Effect of pain in pediatric inherited neuropathies (2014) (16)
- Editorial [Hot Topic: Diabetic Neuropathy (Guest Editor: Eva L. Feldman)] (2008) (16)
- Idiopathic distal sensory polyneuropathy (2020) (16)
- Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells. (2005) (15)
- Potential for promoting recurrent laryngeal nerve regeneration by remote delivery of viral gene therapy (2012) (15)
- Painful Diabetic Neuropathy: Many Similarly Effective Therapies With Widely Dissimilar Costs (2014) (15)
- Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes (2020) (15)
- Integrin-linked kinase complexes with caveolin-1 in human neuroblastoma cells. (2005) (15)
- In situ imaging of mitochondrial outer-membrane pores using atomic force microscopy. (2004) (15)
- The natural history of a “benign” rib lesion in a patient with a demyelinating polyneuropathy and an unusual variant of poems syndrome (1994) (14)
- Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy (2020) (14)
- Can drug screening lead to candidate therapies for testing in diabetic neuropathy? (2008) (14)
- Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes (2021) (14)
- Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes (2019) (14)
- Human neural stem cell transplantation into the corpus callosum of Alzheimer's mice (2017) (14)
- Burden of Diabetic Peripheral Neuropathy in Pima Indians With Type 2 Diabetes (2016) (14)
- Effect of Motor versus Sensory Nerve Autografts on Regeneration and Functional Outcomes of Rat Facial Nerve Reconstruction (2019) (14)
- A novel approach to study motor neurons from zebrafish embryos and larvae in culture (2012) (14)
- Effect of mild hyperglycemia on autonomic function in obstructive sleep apnea (2012) (13)
- Remote Adenoviral Gene Delivery to the Spinal Cord: Contralateral Delivery and Reinjection (2001) (13)
- Acute effects of adrenergic-mediated ischemia on nerve conduction in subjects with type 2 diabetes. (1999) (13)
- Glial-neuron crosstalk in health and disease: A focus on metabolism, obesity, and cognitive impairment (2022) (12)
- Stem Cell Therapies for Amyotrophic Lateral Sclerosis : Recent Advances and Prospects for the Future (2014) (12)
- p 38 mediates mechanical allodynia in a mouse model of type 2 diabetes (2010) (11)
- Design-Based stereology and binary image histomorphometry in nerve assessment (2020) (11)
- Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact (2021) (11)
- Peptides stimulate phosphoinositide hydrolysis in human retinal pigment epithelium. (1993) (11)
- Immunohistologic analysis of spontaneous recurrent laryngeal nerve reinnervation in a rat model (2018) (11)
- Visualization of Mitochondrial DNA Replication in Individual Cells by EdU Signal Amplification (2010) (11)
- Capturing cases of distal symmetric polyneuropathy in a community (2012) (11)
- Distal Symmetric Polyneuropathy in 2020. (2020) (11)
- Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines. (2001) (11)
- Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice (2017) (11)
- Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts (2022) (10)
- Progress in inflammatory neuropathy —the legacy of Dr Jack Griffin (2015) (10)
- Excitotoxicity hypothesis. Discussion (1996) (10)
- Lectin binding to neurites of goldfish retinal explants (1982) (10)
- Prognosis in long-term immunosuppressive treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy. (1992) (10)
- Statin Therapy and Risk of Polyneuropathy in Type 2 Diabetes: A Danish Cohort Study (2020) (10)
- Computational methods for predicting sites of functionally important dynamics. (2009) (10)
- Therapeutic hypothermia after cardiac arrest without return of consciousness: skating on thin ice. (2014) (10)
- A new member of the multidisciplinary ALS team: The otolaryngologist (2012) (10)
- Differential regulation of insulin receptor substrate-1 degradation during mannitol and okadaic acid induced apoptosis in human neuroblastoma cells. (2005) (10)
- NK cells associate with ALS in a sex- and age-dependent manner (2021) (10)
- Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells. (1993) (10)
- Intraspinal transplantation of neurogenin-expressing stem cells generates spinal cord neural progenitors (2012) (9)
- Insulin‐like Growth Factor Binding Protein Expression in Human Retinal Pigment Epithelial Cells (1993) (9)
- Amyotrophic Lateral Sclerosis Survival Associates With Neutrophils in a Sex-specific Manner (2021) (9)
- Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis (2020) (9)
- The Impact of the COVID-19 Pandemic on Ethnic Minority Groups With Diabetes. (2022) (9)
- DIAGNOSIS AND TREATMENT OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY (2021) (9)
- PKC activity and PKC-alpha mRNA content are reduced in serum-derived human neuroblastoma cells without concomitant induction of differentiation. (1993) (8)
- Voicing the Need for Amyotrophic Lateral Sclerosis Environmental Research. (2020) (8)
- Differential impact of type-1 and type-2 diabetes on control of heart rate in mice (2016) (8)
- Defining disability: development and validation of a mobility-Disability Severity Index (mDSI) in Charcot-Marie-tooth disease (2014) (8)
- Targeted intraspinal injections to assess therapies in rodent models of neurological disorders (2019) (8)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) meeting summary: Advances toward measuring diabetic retinopathy and neuropathy: from the bench to the clinic and back again (April 4-5, 2007, Baltimore, Maryland). (2009) (8)
- High Dietary Fat Consumption Impairs Axonal Mitochondrial Function In Vivo (2021) (8)
- Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone (2019) (8)
- Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments (2022) (8)
- Variable Selection with Multiply-Imputed Datasets: Choosing Between Stacked and Grouped Methods (2020) (8)
- The metabolic drivers of neuropathy in India. (2018) (7)
- Clinical Trials of Therapies for Amyotrophic Lateral Sclerosis: One Size Does Not Fit All. (2015) (7)
- Nox, Nox, Are You There? The Role of NADPH Oxidases in the Peripheral Nervous System. (2021) (7)
- The tyrosine kinase inhibitor methyl 2,5-dihydroxycinnimate disrupts changes in the actin cytoskeleton required for neurite formation. (1996) (7)
- Diffusion tensor imaging of the sural nerve in normal controls. (2014) (7)
- Associations of self-reported occupational exposures and settings to ALS: a case–control study (2022) (7)
- Novel Model to Assess Laryngeal Function, Innervation, and Reinnervation (2011) (7)
- Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model (2021) (7)
- Dysregulated biodynamics in metabolic attractor systems precede the emergence of amyotrophic lateral sclerosis (2020) (7)
- Clinical Management of Diabetic Neuropathy (1998) (7)
- Regulation of insulin-like growth factor-IL expression and its role in autocrine growth of human neuroblastoma cells. (1993) (7)
- Automated difference image analysis of lamellar ruffling: effect of temperature change on human SH-SY5Y neuroblastoma cells (2000) (6)
- The Diabetic Neuropathies (1953) (6)
- Dietary weight loss in people with severe obesity stabilizes neuropathy and improves symptomatology (2021) (6)
- Diabetic neuropathy in children and youth: New and emerging risk factors (2020) (6)
- Computational methods for identifying a layered allosteric regulatory mechanism for ALS‐causing mutations of Cu‐Zn superoxide dismutase 1 (2011) (6)
- Pathogenesis of Diabetic Neuropathy from the Point of View of Schwann Cell Abnormalities (2014) (6)
- Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci (2016) (6)
- Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status. (2021) (6)
- Development and characterisation of an experimental recurrent laryngeal nerve injury model for the study of viral gene therapy (2007) (6)
- Advances in diet-induced rodent models of metabolically acquired peripheral neuropathy. (2021) (6)
- How neurologists can choose (even more) wisely: prioritizing waste reduction targets and identifying gaps in knowledge. (2014) (5)
- Diabetic Complication Models SOD 2 Protects Neurons from Injury in Cell Culture and Animal Models of Diabetic Neuropathy (2007) (5)
- Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model. (2021) (5)
- Current landscape in motoneuron regeneration and reconstruction for motor cranial nerve injuries (2020) (5)
- The evaluation of distal symmetric polyneuropathy: utilisation and expenditures by community neurologists (2015) (5)
- Obesity-induced neuroinflammation and cognitive impairment in young adult versus middle-aged mice (2022) (5)
- Evaluation of sham non‐invasive ventilation for randomized, controlled trials in ALS (2006) (5)
- Extracellular Vesicles in Serum and Central Nervous System Tissues Contain microRNA Signatures in Sporadic Amyotrophic Lateral Sclerosis (2021) (5)
- Peripheral Nerve Disorders (2007) (5)
- Establishment, maintenance, and transfection of in vitro cultures of human retinal pigment epithelium. (2005) (5)
- Mononeuropathy multiplex in tryptophan‐associated eosinophilia‐myalgia syndrome (1990) (5)
- Insulin‐like Growth Factor Binding Protein Expression in SH‐SY5Y Neuroblastoma Cells (1993) (5)
- Atlas of Neuromuscular Diseases: A Practical Guideline (2004) (5)
- Antisense Oligonucleotides for Duchenne Muscular Dystrophy: Why No Neurologist Should Skip This. (2016) (5)
- Treatment of Diabetic Neuropathy (2010) (4)
- Differential effects of minocycline on microvascular complications in murine models of type 1 and type 2 diabetes (2020) (4)
- Neurophilins and the nervous system (1999) (4)
- Electrodiagnostic Tests in Polyneuropathy and Radiculopathy. (2016) (4)
- Electrodiagnostic tests are unlikely to change management in those with a known cause of typical distal symmetric polyneuropathy (2017) (4)
- Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects (2021) (4)
- cGAS/STING and innate brain inflammation following acute high-fat feeding (2022) (4)
- Michigan Neuropathy Screening Instrument (2018) (4)
- Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study (2018) (4)
- Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy (2013) (4)
- IGF-I in Neuronal Differentiation and Neuroprotection (1998) (4)
- Natural killer cells associate with amyotrophic lateral sclersois in a sex- and age-dependent manner. (2021) (4)
- ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes (2022) (3)
- Etiology of diabetic microvascular disease and scientific rationale for new therapeutic targets (2005) (3)
- The Italian multicentre study on the prevalence of distal symmetric polyneuropathy: correlation between clinical variables and nerve conduction parameters. Italian Diabetic Neuropathy Committee. (1999) (3)
- Facial Nerve Surgery in the Rat Model to Study Axonal Inhibition and Regeneration. (2020) (3)
- Reversibility of Serum Removal Effects on IGF‐II mRNA in Human Neuroblastoma Cells (1993) (3)
- Tofacitinib Suppresses Natural Killer Cells In Vitro and In Vivo: Implications for Amyotrophic Lateral Sclerosis (2022) (3)
- Response to Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226–1232 (2018) (3)
- Atlas of neuromuscular diseases (2014) (3)
- Measuring neuropathy in obese populations: Challenge accepted. Reply to “Diagnostic accuracy of neuropathy tests in obese population remains elusive” (2018) (3)
- Neuronal and Schwann Cell Death in Diabetic Neuropathy (2007) (3)
- PTEN / MMAC 1 Overexpression Decreases Insulin-like Growth Factor-I-mediated Protection from Apoptosis in Neuroblastoma Cells 1 (2001) (3)
- Differential Regulation of Insulin Receptor Substrate-2 and Mitogen-Activated Protein Kinase Tyrosine Phosphorylation by Phosphatidylinositol 3-Kinase Inhibitors in SH-SY5Y Human Neuroblastoma Cells* * This work was supported by NIH Grants R29-NS-32843 and R01-NS-36778, grants from the American Diab (1998) (3)
- Comparison of Myelin-Associated Glycoprotein With Vincristine for Facial Nerve Inhibition After Bilateral Axotomy in a Transgenic Thy1-Gfp Rat Model. (2019) (3)
- Neurodegeneration and early lethality in SOD2-deficient mice: a comprehensive analysis of the central and peripheral nervous systems (2012) (3)
- Review ■ : Insulin-like Growth Factor-I and Apoptosis in Glial Cell Biology (2000) (3)
- Lessons for clinical trial design in Friedreich's ataxia (2021) (2)
- Peripheral Neuropathy in Adolescents andYoungAdultsWithType 1 andType 2 Diabetes From the SEARCH for Diabetes in Youth Follow-Up Cohort A pilot study (2013) (2)
- Magnetic resonance imaging of human neural stem cells in rodent and primate brain (2020) (2)
- Stem Cell Therapy for Motor Neuron Disease (2014) (2)
- Diabetes and dementia: Clinical perspective, innovation, knowledge gaps. (2022) (2)
- Establishment and maintenance of in vitro cultures of human retinal pigment epithelium. (1996) (2)
- Diabetes and Cognitive Dysfunction (2015) (2)
- DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes (2020) (2)
- Minireview: Insulin-Like Growth Factors in the Peripheral Nervous System (2008) (2)
- Histological Bulbar Manifestations in the ALS Rat (2015) (2)
- A brighter future for patients with amyotrophic lateral sclerosis through imaging? (2014) (2)
- 106) Upregulation of nerve growth factor signaling in painful neuropathy of type 2 diabetes (2008) (2)
- Results of an International Corneal Confocal Microscopy (CCM) Consortium: A Pooled Multicentre Analysis of the Concurrent Diagnostic Validity of CCM to Identify Diabetic Polyneuropathy in Type 1 Diabetes Mellitus (2016) (2)
- Correction to: Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone (2019) (2)
- ALS/SURV: a modification of the CAFS statistic (2019) (2)
- Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review (2022) (2)
- Therapeutic hypothermia and targeted temperature management after cardiac arrest-reply. (2014) (2)
- Taurine Replacement Prevents Apoptosis In Experimental Diabetic Neuropathy (2000) (2)
- Diabetic neuropathy: the future is promising. Reply to Uusitupa M, Niskanen L, Laitinen T [letter] and Coppini DV [letter] (2020) (2)
- Cytoskeleton, Axonal Transport, and the Mechanisms of Axonal Neuropathy (2011) (2)
- LOX-1-mediated injury in sensory neurons in type 2 diabetes (2012) (2)
- Amyloid Myopathy Presenting with Dysphagia and an Inclusion Body Myositis Phenotype (P2.119) (2017) (1)
- Delivery of Interleukin‐4–Encoding Lentivirus Using Multiple‐Channel Bridges Enhances Nerve Regeneration (2020) (1)
- The Spectrum of Motor Neuron Diseases: From Childhood Spinal Muscular Atrophy to Adult Amyotrophic Lateral Sclerosis (2015) (1)
- Energizing the Conversation: How to Identify and Overcome Gender Inequalities in Academic Medicine. (2020) (1)
- The DCCT, metabolism and diabetic neuropathy: perspectives for the fourth international symposium on diabetic neuropathy (1997) (1)
- Insulin-Like Growth Factors and Nervous System Disorders (2004) (1)
- Obesity and the nervous system: more questions – Authors' reply (2017) (1)
- 531-P: Metabolomics Identifies Novel Plasma Metabolomic Signatures Associated with Diabetic Neuropathy in a Cohort with Screen-Tested Type 2 Diabetes: ADDITION-Denmark (2020) (1)
- Neuromuscular effects of G93A-SOD1 expression in zebrafish (2012) (1)
- Characterization of C9orf72 haplotypes to evaluate the effects of normal and pathological variations on its expression and splicing (2021) (1)
- The conundrum of diabetic neuropathies-Past, present, and future. (2022) (1)
- Amelioration of Peripheral Neuropathy in Mouse Models of Diabetes by Dietary Reversal (2018) (1)
- A High-Fat Diet Disrupts Nerve Lipids and Mitochondrial Function in Murine Models of Neuropathy (2022) (1)
- The Spectrum of Motor Neuron Diseases: From Childhood Spinal Muscular Atrophy to Adult Amyotrophic Lateral Sclerosis (2015) (1)
- miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis. (2022) (1)
- The myo-inositol (MI) depletion hypothesis of diabetic complications (1992) (1)
- Metabolism, cognition, and the brain throughout life (2019) (1)
- Diabetic Nerve Disease, Neuropathy (2004) (1)
- NOX, NOX, Are You Here? The Emerging Role of NOX5 in Diabetic Neuropathy (2018) (1)
- 532-P: The Longitudinal Determinants of Diabetic Complications in the Pima Indians of Arizona (2020) (1)
- Metabolic factors, lifestyle habits, and possible polyneuropathy in early type 2 diabetes: A nationwide study of 5,249 patients in the Danish DD2 cohort (2020) (1)
- Autonomic Neuroscience: Basic and Clinical (2013) (1)
- Erratum: Stem cell technology for the study and treatment of motor neuron diseases, which appeared in the February issue of Regenerative Medicine (Regen. Med. (2011) 6:2 (201-213)) (2011) (1)
- Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes (2022) (1)
- Applying database technology to clinical and basic research bioinformatics projects. (2003) (1)
- Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles (2022) (1)
- The determinants of complication trajectories in American Indians with type 2 diabetes (2021) (1)
- Scaffold for facial nerve reconstruction (2019) (1)
- A 2020 centenary perspective on neuromuscular disorders (2020) (1)
- Interferon-y Inhibits DNA Synthesis and Insulin-Like Growth Factor41 Expression in Human Neuroblastoma Cells (2004) (1)
- Systems Biology to Address Unmet Medical Needs in Neurological Disorders. (2022) (1)
- 461-P: Prevalence and Patient Recognition of Distal Symmetric Neuropathy (DSP) in a Predominantly Low-Income U.S. Patient Population (2022) (1)
- Disrupted axon-glia communication leads to neurodegeneration in metabolic diseases (2023) (0)
- (307) Reduced intradermal nerve fiber density follows sustained increases in insular glutamate: a pilot study examining the potential pathogenesis of small fiber pathology in fibromyalgia (FM) (2017) (0)
- Systems Pharmacology Approach to Identify Potential Therapeutic Small‐Molecules for Treatment of Diabetic Peripheral Neuropathy (2016) (0)
- Neuropathy Phentoyping Protocols - Immuno-Electron Microscopy v1 (2019) (0)
- Peripheral nervous system insulin resistance in ob/ob mice (2013) (0)
- Toll-Like Receptors 2/4 and Diabetic Peripheral Neuropathy (2018) (0)
- Principles of Peripheral Nerve Surgery (2021) (0)
- Mig-2 is required for normal myogenesis in zebrafish (2007) (0)
- P1.36 Zebrafish models of dynamin 2 – related centronuclear myopathy (2010) (0)
- G.P.12.05 Myotubularins and the pathogenesis of centronuclear myopathies (2009) (0)
- EM.P.5.05 Zebrafish models of collagen VI myopathies (2009) (0)
- Circuits and Circuit Disorders: Approaches to Neuromodulation: Call for Papers and New Initiative With the American Neurological Association and the Annals of Neurology (2015) (0)
- Chronic Pain in Peripheral Neuropathy (2021) (0)
- 322-OR: Risk Factors for Peripheral and Cardiovascular Autonomic Neuropathy in Type 1 Diabetes: Thirty Years of Follow-Up in DCCT/EDIC (2019) (0)
- High-Fat Diet Induces Mitochondrial Dysfunction in Saphenous Nerve Axons—A Study by Confocal Microscopy In Vivo (2018) (0)
- Occupational history associates with ALS survival and onset segment (2022) (0)
- NeuronsSpontaneous EPSCs in Cultured Cortical - Effect of Conantokin G on NMDA Receptor (2015) (0)
- Apoptosis and Human Diseases: Molecular Mechanisms (2006) (0)
- Title Page Full Title Epigenetic Changes in Bone Marrow Progenitor Cells Influence the Inflammatory Phenotype and Alter Wound Healing in Type 2 Diabetes Short Running Title Epigenetics Impair Diabetic Wound Healing Authors (2014) (0)
- Correction to: Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy (2020) (0)
- Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers. (2017) (0)
- Correction to: Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy (2020) (0)
- Reduced motor cortex GABA in amyotrophic lateral sclerosis (2011) (0)
- Miro1‐directed mitochondrial movement protects against neurodegeneration in mice (234.3) (2014) (0)
- Tubulin involvement in Bortezomib peripheral neurotoxicity (2016) (0)
- Inclusion body myositis: small steps towards future advances (2021) (0)
- Reply to “Diagnosing Neuropathy in an Obese Patient”: Measuring neuropathy in obese populations: Nerve conduction studies (2018) (0)
- Advances in diagnosis and management of distal sensory polyneuropathies (2023) (0)
- Amyotrophic lateral sclerosis from genotoxins alone? – Authors' reply (2022) (0)
- ALSUntangled #67: rituximab. (2022) (0)
- ALSUntangled # 69: astaxanthin. (2023) (0)
- Integration of text mining with systems biology provides new insight into the pathogenesis of diabetic neuropathy (2010) (0)
- BOOK REVIEWS The Neuropathology of Dementia, 2nd Edition (2005) (0)
- A Role for Fatty Acids in Peripheral Neuropathy Associated with Type 2 Diabetes and Prediabetes. (2022) (0)
- Response to Caro and Winter (2019) (0)
- The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity (2023) (0)
- Title: Defective tubulation associated with the myopathy causing S619L DNM2 mutation Running title: Pathogenesis of DNM2 mutation (2013) (0)
- Neuropathy Phentoyping Protocols - Streptozotocin Treatment For Rats v1 (2019) (0)
- Motor Neuron Diseases (2021) (0)
- Epigenetic miRNA dysregulation as a mechanism for sporadic amyotrophic lateral sclerosis (2013) (0)
- WITHDRAWN: Mig-2 is required for normal myogenesis in zebrafish (2007) (0)
- Neuromuscular AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISEASES (2008) (0)
- Atlas of Neuromuscular Diseases: E-Book (2015) (0)
- Western Analysis used in Oxidative Stress Protocols v1 (2019) (0)
- Reply (2012) (0)
- Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics (2023) (0)
- A Physician Survey of Clinical Practice (2016) (0)
- Table of Contents (2020) (0)
- Chapter 21 – Diabetes and the Nervous System (2008) (0)
- Biomedical research: a culture in crisis? (2005) (0)
- Biochemical Measures of Neuropathy - Genotyping v1 (2019) (0)
- New Neuromuscular Therapies (2021) (0)
- JAMA Neurology Peer Reviewers in 2017. (2018) (0)
- The determinants of complication trajectories in American Indians with type 2 diabetes (2023) (0)
- 1992-P: Metabolic Factors Associated with Cognitive Function and Brain Morphology in Type 2 Diabetes (2020) (0)
- Emergency Department Stroke Care. (2017) (0)
- 125-OR: Polyunsaturated Omega-6 Fatty Acids Reduce Axonal Mitochondrial Trafficking in Dorsal Root Ganglion Sensory Neurons (2020) (0)
- Bioenergetic Metabolites in the Diabetic Peripheral Nervous System (P03.193) (2012) (0)
- Incorrect Data Used in Statistical Analyses. (2017) (0)
- Rehabilitation Medicine , and the American Academy of Physical Medicine and American Association of Neuromuscular and Electrodiagnostic neuropathy : Report of the American Academy of Neurology , the Evidence-based guideline : Treatment of painful diabetic April (2011) (0)
- Useful Biomarkers for the Diagnosis of Painful Diabetic Neuropathy (IN1-1.004) (2012) (0)
- List of contributors (2019) (0)
- Two-Way Orthogonal Partial Least Squares (O2PLS) Analysis of the Lipidome and Transcriptome in Prediabetic and Diabetic Neuropathy (2018) (0)
- Immunosuppressive Treatment in Multhocal Motor Neuropathy (1991) (0)
- Abstract 145: Epigenetic Modifications of Bone-Marrow Progenitor Cells Promote an M1 Phenotype in Peripheral Macrophages in Diabetes (2012) (0)
- Modeling the innate inflammatory cGAS/STING pathway: sexually dimorphic effects on microglia and cognition in obesity and prediabetes (2023) (0)
- The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain (2015) (0)
- Epigenetic Modifications of IL-12 Gene Expression in Bone Marrow Hematopoietic Stem Cells Promote An M1, Pro-inflammatory Phenotype in Diabetic Peripheral Macrophages (2013) (0)
- Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis (2015) (0)
- 1158-P: The Effect of Surgical Weight Loss on Diabetic Complications in the Severely Obese (2022) (0)
- 529-P: Insulin Replacement Therapy Does Not Fully Prevent Peripheral Neuropathy in Type 1 Diabetic Mice (2020) (0)
- Genetic Testing in Neuromuscular Diseases (2021) (0)
- Letters to the editor (1993) (0)
- Targeted intraspinal injections to assess therapies in rodent models of neurological disorders (2019) (0)
- Neuropsychological Outcomes in Individuals With Type 1 and Type 2 Diabetes (2022) (0)
- Single-cell RNA sequencing identifies hippocampal microglial dysregulation in diet-induced obesity (2023) (0)
- Neuropathy Phentoyping Protocols - Nerve Conduction Velocity v2 (2019) (0)
- Neuropathy Phentoyping Protocols - Transmission Electron Microscopy v1 (2019) (0)
- Neuropathy Phentoyping Protocols - Nerve Conduction Velocity v1 (2019) (0)
- Biochemical Measures of Neuropathy - DHE v1 (2019) (0)
- Biochemical Measures of Neuropathy -- Glutathione S-Transferase v1 (2019) (0)
- Biochemical Measures of Neuropathy - Hydrogen Peroxide Assay v1 (2019) (0)
- Nerve Conduction Velocity Tests v1 (2019) (0)
- Neuropathy Phentoyping Protocols - Insulin Implantation Protocol v2 (2019) (0)
- Biochemical Measures of Neuropathy - Hydrogen Peroxide Assay v2 (2019) (0)
- Biochemical Measures of Neuropathy - Glutathione Peroxidase v1 (2019) (0)
- Neuropathy Phentoyping Protocols - Hematoxylin and Eosin Staining v1 (2019) (0)
- Treatment-induced neuropathy of diabetes: an underdiagnosed entity – Authors' reply (2023) (0)
- Computational Methods for Predicting Sites of Functionally Important Dynamics (2009) (0)
- R426 – Muscle-Nerve-Muscle Neurotization of the Rat Larynx (2008) (0)
- Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias (2023) (0)
- Neuropathy Phentoyping Protocols - Immunohistochemistry for Tissue Sections v1 (2019) (0)
- Neuropathy Phentoyping Protocols - Insulin Implantation Protocol v1 (2019) (0)
- Biochemical Measures of Neuropathy - Western Blot Stripping v1 (2019) (0)
- Nerve Conduction Velocity Tests v2 (2019) (0)
- Neuropathy Phentoyping Protocols - Dosages of Analgesics for Rats and Mice v1 (2019) (0)
- Motor neuron growth factors. Discussion (1996) (0)
- Neuromuscular diseases: Therapies on the horizon (2021) (0)
- Biochemical Measures of Neuropathy - Lowry Protein Assay v1 (2019) (0)
- Western Analysis used in Oxidative Stress Protocols v2 (2019) (0)
- Colon and Anorectum (2021) (0)
- Biochemical Measures of Neuropathy - Glutathione Reductase v1 (2019) (0)
- Neuropathy Phentoyping Protocols - Immunohistochemistry for Tissue Sections v2 (2019) (0)
- Biochemical Measures of Neuropathy - Glutathione Assay (GSH) v1 (2019) (0)
- Saturated Fatty Acids Impair Organellar Trafficking in Dorsal Root Ganglion (DRG) Sensory Neurons (2018) (0)
- Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes (2019) (0)
- Microvascular complications of impaired glucose tolerance. Perspectives in diabetes (2004) (0)
- Amyotrophic Lateral Sclerosis, Occupational Risk Factors and Exposure Windows: a Case-Control Study in Michigan (2014) (0)
- The Management of Diabetic Neuropathy in CKD and Dialysis Patients (2014) (0)
- Conserved Transcriptional Signatures in Human and Murine Diabetic Peripheral Neuropathy (2018) (0)
- Di ff erential E ff ects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes (2020) (0)
- Large-Scale DNA Methylation Profiling of Human Diabetic Peripheral Neuropathy in Subjects with Type 2 Diabetes Mellitus (2018) (0)
- Immune-mediated vincristine-induced neuropathy: Unlocking therapies (2021) (0)
- Exploring the optimal diagnostic threshold value of corneal nerve fibre length (CNFL) for diabetic neuropathy (DN) identification (2017) (0)
- Biochemical Measures of Neuropathy - GSSG (Non-Enzymatic) v1 (2019) (0)
- JAMA Neurology Peer Reviewers in 2017. (2018) (0)
- Primary Sensory and Motor Neuron Cultures (2009) (0)
- Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy (2020) (0)
- Comment: Career guidelines promote neurologist satisfaction (2011) (0)
- Chapter 9 – Stem Cell Therapy for Amyotrophic Lateral Sclerosis (2017) (0)
- 31-LB: Identification of Repurposable Drug Candidate for Diabetic Peripheral Neuropathy Using High-Throughput Drug-Perturbation Data (2019) (0)
- Monounsaturated Fatty Acids Prevent Saturated Fatty Acid–Induced Impairment of Mitochondrial Trafficking in Dorsal Root Ganglion Sensory Neurons (2018) (0)
- ALSUntangled #68: ozone therapy. (2022) (0)
- 460-P: Cellular Communication of Schwann Cell Subtypes in Metabolically-Acquired Neuropathy (2022) (0)
- Principles of Nerve and Muscle Rehabilitation (2021) (0)
- 2285-PUB: Hippocampal Transcriptomic Changes Due to High-Fat Diet in Prediabetic Mice (2020) (0)
- Biochemical Measures of Neuropathy - Aconitase v1 (2019) (0)
- Additional perspectives on transforming science into medicine (2012) (0)
- CUTTING-EDGE THEORIES OF PATHOGENESIS OF DIABETIC NEUROPATHY (2007) (0)
- Abnormal RNA stability in amyotrophic lateral sclerosis (2018) (0)
- IN71-FR-03 Dyslipidemia and diabetic neuropathy (2009) (0)
- Traumatic Brain Injury (2021) (0)
- HbA1c is associated with sural nerve regeneration and degeneration in diabetic neuropathy (2013) (0)
- Effect of Motor versus Sensory Nerve Autografts on Regeneration and Functional Outcomes of Rat Facial Nerve Reconstruction (2019) (0)
- Books Received (2005) (0)
- OBESITY-INDUCED INSULIN RESISTANCE INCREASES APP T668 PHOSPHORYLATION AND IMPAIRS COGNITIVE FUNCTION (2014) (0)
- 458-P: Inflammatory Markers and Cardiovascular Autonomic Neuropathy in Type 1 Diabetes (2022) (0)
- NADPH oxidase 5: A new player in peripheral neuropathy (2021) (0)
- Human neural stem cell transplantation improves cognition in a murine model of Alzheimer’s disease (2018) (0)
- Biochemical Measures of Neuropathy - (H2) DCFDA v1 (2019) (0)
- 537-P: Dietary Reversal Improves Peripheral Neuropathy and Gut Microbiota Profile in a Murine Model of Prediabetes and Obesity (2020) (0)
- Obesity and metabolic risk factors associated with non-painful and painful diabetic polyneuropathy: a nationwide prevalence study of 5,249 patients in the Danish DD2 cohort (2019) (0)
- Leprosy as a Cause of Distal Symmetric Polyneuropathy--Reply. (2016) (0)
- Innate immune cGAS/STING in HFD‐induced obesity, prediabetes, and cognitive impairment (2022) (0)
This paper list is powered by the following services:
Other Resources About Eva Feldman
What Schools Are Affiliated With Eva Feldman?
Eva Feldman is affiliated with the following schools: